WEST BLOOMFIELD TOWNSHIP, MI / / October 31, 2024 / Cerebral Palsy Research Network, Hope for HIE and Newborn Brain Society announce a partnership and receipt of funding to develop a patient registry ...
pH <7 or base deficit of 16 mmol/L and evidence of moderate or severe encephalopathy (Sarnet score) and aEEG recording used to control for the severity of injury. Method: Head cooling with cooling ...
Neonatal hypoxic-ischemic encephalopathy disproportionately affects low- and middle-income countries, where ≈96% of affected infants reside. The current standard of care, therapeutic hypothermia, is ...
Our current work is focussed on developing effective disease stratification tools for developing personalised neuroprotection in neonatal encephalopathy and evaluating these using quantitative MR ...
About 1 in 10 cases of cerebral palsy are caused by lack of oxygen to the brain around the time of birth, commonly called birth asphyxia or hypoxic-ischemic encephalopathy. Researchers at UCSF used ...
ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...
Keywords: Neuroprotection, Therapeutic Hypothermia, Diagnostic Biomarkers, Neonatal Outcomes, Socio-economic Disparities in Treatment Important Note: All contributions to this Research Topic must be ...